18187-Lymphomas-Non-Hodgkins-56

Lymphomas

AN OPEN-LABEL, MULTICENTER, PHASE I/IB TRIAL EVALUATING THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF ESCALATING DOSES OF MOSUNETUZUMAB (BTCT4465A) AS A SINGLE AGENT AND COMBINED WITH ATEZOLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN�S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA (GO29781)

  • Details

ClinicalTrials.gov ID: NCT02500407
Diagnosis Type: Non-Hodgkins
USOR Number:

  • Address

4715 Arapahoe Avenue
Boulder, CO 80303
P: (303) 385-2068

Search by practice name, trial titles, indicators and specific disease types.

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.